Lead Researcher Spotlight Professor Frank Ng, PhD Department of Biochemistry and Molecular Biology Monash University, Melbourne, Australia Professor Frank Ng led the pioneering research team that developed AOD-9604 in the 1990s as part of efforts to create a targeted anti-obesity therapeutic derived from human growth hormone
TB-500 is most commonly injected subcutaneously in the abdominal fat pad, but intramuscular injection is also used depending on the protocol
Higher Upfront Cost: While the cost per dose might be higher than oral supplements, the less frequent dosing schedule can sometimes balance out the expense over time
Peptide blends Pre-formulated peptide blends like the wolverine stack (BPC-157 + TB-500) or glow peptide blends (TB-500 + BPC-157 + GHK-Cu) come with multiple peptides in a single vial
Can women use AOD 9604 during menopause
MOTS-c is often promoted for metabolism and weight loss, but it should not be placed in the same category as approved weight-loss injections with established clinical evidence